Should I buy Lazard (LAZ) stock or is it too late?

Lazard · Financials · price $37
Logo LazardSee the full Lazard (LAZ) profile
⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: Keefe, Bruyette & Woods — 67% of its targets hit on this sector (296 calls tested). It aims for $42 (+15 %), call made on July 25, 2026, maturing on July 25, 2027 (81 d ago).

The 1 reliable analyst $42+15 %
The 4 other firms $40.50+11 %
How to read it: the 1 reliable firms are not filtered by optimism — 1 aim above the price, 0 below, hence their $42 median. “The 4 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on Lazard

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.
Firm% rightGain vs sectorCallsAims for
Morgan Stanley67 %+7.0 %6$41 +12%
In short — Should you invest in Lazard? Is it too late, still worth it? Analysts are split (20% buy, median target $41, i.e. +12%), and the most reliable on LAZ targets even higher. But it pays virtually no dividend. We give you both sides, with the numbers — not advice.

✅ Reasons to believe

  • Median price target $41, i.e. +12% from the current price ($37).
  • The most reliable firm on LAZ, Morgan Stanley (67% hit rate, 6 scored calls), targets $41 (call made on October 8, 2026, maturing on October 8, 2027) (+12%) in its most recent call, and $61 (call made on December 11, 2025, maturing on December 11, 2026) (+67%) in the one coming due soonest.

⚠️ Reasons to hesitate

  • The consensus is not unanimous: of 5 ratings, 2 are neutral and 2 are sells.
  • A 12-month target is not a guaranteed path: the price can fall in the meantime.
  • No dividend: your return depends only on price appreciation.

The analyst consensus on LAZ

Median target $41 (+12%) · 5 ratings · Hold consensus

Strong Buy00%
Buy120%
Hold240%
Sell240%
Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in Lazard now?

We won't decide for you. The facts: 20% of analysts rate it a buy, median target $41 (+12%), and Morgan Stanley (most reliable on LAZ, 67%) targets $41. Weigh that against valuation. This is not personalized advice.

Is it too late to invest in Lazard?

Not according to analysts: the median target ($41) is still +12% above the current price ($37) (most reliable on LAZ: Morgan Stanley, 67%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is Lazard still worth investing in?

It depends on the gap between the price ($37) and its estimated value: analysts target $41 on median (+12%), with 20% buys (most reliable on LAZ: Morgan Stanley, 67%). Cross-check with their real reliability on LAZ and the cautions above. Information, not advice.

What's the main risk in buying LAZ?

The consensus is not unanimous: of 5 ratings, 2 are neutral and 2 are sells.

→ Go deeper: the full Lazard profile (consensus, analyst reliability, price target, performance).

JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)